Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Shuttle Pharma to acquire Molecule.ai to boost cancer drug development with AI.
Shuttle Pharma has signed a definitive letter of intent to acquire Molecule.ai, aiming to leverage the latter's AI-driven drug discovery platform to enhance its oncology pipeline.
The move positions radiation therapy as a more targeted treatment by integrating advanced molecular analysis.
The deal, pending final due diligence, could accelerate development of precision cancer therapies.
5 Articles
Shuttle Pharma adquirirá Molecule.ai para impulsar el desarrollo de fármacos contra el cáncer con IA.